OptiBiotix joins Probiota Europe 2019

The human microbial strains expert will showcase research and new developments in prebiotics, probiotics and the microbiome

Stephen O’Hara, OptiBiotix CEO

Gearing up for Probiota Europe 2019, OptiBiotix Health has said a team of experts will attend the event in Denmark to demonstrate progressive research and new developments in prebiotics, probiotics and the microbiome.

Stephen O’Hara, OptiBiotix CEO, explained: “Probiota is a premier event and we are excited to showcase our latest knowledge and expertise, which is backed by key professors in the field of microbiome science and clinical style human studies.”

Three abstracts created by the experts at OptiBiotix will be displayed at the event. The presentation focus on topics including the impact of sweet dietary fibres (SweetBiotix) on the human faecal microbiome, the effect of functional ingredients on weight loss and gut microbiome composition and the antimicrobial activity of probiotics against pathogens of clinical relevance.

OptiBiotix’s abstracts will be portrayed in a special poster viewing element of the event, the ‘Probiota 2019 Scientific Frontiers session’.

Nutraceutical focus

Probiota Europe 2019 takes place on 13-15 February at Scandic Copenhagen. The event combines the latest insights from science, regulation and business to provide delegates with the ultimate event to bridge the gap between the worlds of business, regulation, research and product development in the rapidly growing and overlapping fields of probiotics, prebiotics and the microbiome.

Over the three days, there will also be key updates from the IPA, alongside regulatory insights from top experts, and sessions looking at how proposed taxonomic changes will affect businesses or research.

Companies